Tag: Cancer: Prostate
Comorbid CVD May Up Mortality With ADT for Prostate Cancer
Seniors with preexisting cardiovascular diseases have higher risk for short-term mortality with AA, ENZ
Adjuvant RT May Cut Recurrence in Some With Prostate Cancer
Adjuvant radiotherapy after surgery may prolong biochemical recurrence-free survival
Androgen Deprivation Therapy May Up Risk of Alzheimer Disease
ADT exposure linked to subsequent Alzheimer disease diagnosis among elderly men at eight years
Urine Biomarker Helps Classify Risk Level in Prostate Cancer
Urine-derived extracellular vesicle RNA provides diagnostic, prognostic information in prostate cancer
Combination Biopsy Strategy May Identify More Prostate Cancers
Lesion-targeted plus systematic sampling appears to maximize the accuracy of first-time prostate biopsy
Black Race Not Tied to Worse Prostate Cancer Mortality
Findings seen in cohorts of men with nonmetastatic disease after adjusting for nonbiological differences
Location of Body Fat Linked to Advanced, Fatal Prostate Cancer
Risk for advanced, fatal disease also increased in association with body mass index, waist circumference
Fewer Black Men Adopt Active Surveillance for Prostate Cancer
Overall, use of active surveillance nearly tripled among both black and nonblack men from 2010 to 2015
ASCO: Enzalutamide Beneficial in Metastatic Prostate Cancer
Progression-free, overall survival longer for men with metastatic, hormone-sensitive prostate cancer
Guidelines Updated for Radiotherapy After Prostatectomy
Updates include adjuvant radiotherapy for patients with adverse pathologic findings, hormonal therapies
